Formulation design of bilayer dual-release tablet composition of fexofenadine HCl and montelukast sodium

Anuj Narang, Usha Y. Nayak, Bisakha Roy, Reema Narayan

Research output: Contribution to journalArticle

Abstract

The purpose of this study was to develop dual-release bilayer tablets of fexofenadine HCl and montelukast sodium (MKS) to treat the individuals getting symptoms of asthma and allergic rhinitis at late night and early morning which may lead to breathing and respiratory problem. The bilayer tablet was designed to contain fexofenadine for the immediate release and MKS for the extended release matrix. MKS and fexofenadine tablets were prepared separately by direct compression method. The optimized tablets were compressed to obtain bilayer tablets. The tablets were evaluated for various physicochemical parameters and dissolution study. Further, the bilayer tablets were subjected to accelerated stability study. The fexofenadine tablet showing more than 75% release in 15 min and MKS tablet showing more than 90% release at the end of 7 h with 2 h of initial lag time were compressed one above the other to obtain bilayer tablet. The similar release pattern was observed with the bilayer tablets as that of individual tablets. The bilayer tablets were found to be stable at the end of 6 months storage period as per ICH guidelines. Both the layers of the bilayer formulation showed desired drug release at the end of time period, these could be effective formulations in late night and early morning symptoms of asthma and allergic rhinitis.

Original languageEnglish
Pages (from-to)1410-1416
Number of pages7
JournalResearch Journal of Pharmacy and Technology
Volume9
Issue number9
DOIs
Publication statusPublished - 01-09-2016

Fingerprint

fexofenadine
montelukast
Tablets

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Pharmacology (medical)

Cite this

@article{857d276f5ed240d1ad37efa9aa2d5e88,
title = "Formulation design of bilayer dual-release tablet composition of fexofenadine HCl and montelukast sodium",
abstract = "The purpose of this study was to develop dual-release bilayer tablets of fexofenadine HCl and montelukast sodium (MKS) to treat the individuals getting symptoms of asthma and allergic rhinitis at late night and early morning which may lead to breathing and respiratory problem. The bilayer tablet was designed to contain fexofenadine for the immediate release and MKS for the extended release matrix. MKS and fexofenadine tablets were prepared separately by direct compression method. The optimized tablets were compressed to obtain bilayer tablets. The tablets were evaluated for various physicochemical parameters and dissolution study. Further, the bilayer tablets were subjected to accelerated stability study. The fexofenadine tablet showing more than 75{\%} release in 15 min and MKS tablet showing more than 90{\%} release at the end of 7 h with 2 h of initial lag time were compressed one above the other to obtain bilayer tablet. The similar release pattern was observed with the bilayer tablets as that of individual tablets. The bilayer tablets were found to be stable at the end of 6 months storage period as per ICH guidelines. Both the layers of the bilayer formulation showed desired drug release at the end of time period, these could be effective formulations in late night and early morning symptoms of asthma and allergic rhinitis.",
author = "Anuj Narang and Nayak, {Usha Y.} and Bisakha Roy and Reema Narayan",
year = "2016",
month = "9",
day = "1",
doi = "10.5958/0974-360X.2016.00273.0",
language = "English",
volume = "9",
pages = "1410--1416",
journal = "Research Journal of Pharmacy and Technology",
issn = "0974-3618",
publisher = "A and V Publication",
number = "9",

}

Formulation design of bilayer dual-release tablet composition of fexofenadine HCl and montelukast sodium. / Narang, Anuj; Nayak, Usha Y.; Roy, Bisakha; Narayan, Reema.

In: Research Journal of Pharmacy and Technology, Vol. 9, No. 9, 01.09.2016, p. 1410-1416.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Formulation design of bilayer dual-release tablet composition of fexofenadine HCl and montelukast sodium

AU - Narang, Anuj

AU - Nayak, Usha Y.

AU - Roy, Bisakha

AU - Narayan, Reema

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The purpose of this study was to develop dual-release bilayer tablets of fexofenadine HCl and montelukast sodium (MKS) to treat the individuals getting symptoms of asthma and allergic rhinitis at late night and early morning which may lead to breathing and respiratory problem. The bilayer tablet was designed to contain fexofenadine for the immediate release and MKS for the extended release matrix. MKS and fexofenadine tablets were prepared separately by direct compression method. The optimized tablets were compressed to obtain bilayer tablets. The tablets were evaluated for various physicochemical parameters and dissolution study. Further, the bilayer tablets were subjected to accelerated stability study. The fexofenadine tablet showing more than 75% release in 15 min and MKS tablet showing more than 90% release at the end of 7 h with 2 h of initial lag time were compressed one above the other to obtain bilayer tablet. The similar release pattern was observed with the bilayer tablets as that of individual tablets. The bilayer tablets were found to be stable at the end of 6 months storage period as per ICH guidelines. Both the layers of the bilayer formulation showed desired drug release at the end of time period, these could be effective formulations in late night and early morning symptoms of asthma and allergic rhinitis.

AB - The purpose of this study was to develop dual-release bilayer tablets of fexofenadine HCl and montelukast sodium (MKS) to treat the individuals getting symptoms of asthma and allergic rhinitis at late night and early morning which may lead to breathing and respiratory problem. The bilayer tablet was designed to contain fexofenadine for the immediate release and MKS for the extended release matrix. MKS and fexofenadine tablets were prepared separately by direct compression method. The optimized tablets were compressed to obtain bilayer tablets. The tablets were evaluated for various physicochemical parameters and dissolution study. Further, the bilayer tablets were subjected to accelerated stability study. The fexofenadine tablet showing more than 75% release in 15 min and MKS tablet showing more than 90% release at the end of 7 h with 2 h of initial lag time were compressed one above the other to obtain bilayer tablet. The similar release pattern was observed with the bilayer tablets as that of individual tablets. The bilayer tablets were found to be stable at the end of 6 months storage period as per ICH guidelines. Both the layers of the bilayer formulation showed desired drug release at the end of time period, these could be effective formulations in late night and early morning symptoms of asthma and allergic rhinitis.

UR - http://www.scopus.com/inward/record.url?scp=85033489646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033489646&partnerID=8YFLogxK

U2 - 10.5958/0974-360X.2016.00273.0

DO - 10.5958/0974-360X.2016.00273.0

M3 - Article

AN - SCOPUS:85033489646

VL - 9

SP - 1410

EP - 1416

JO - Research Journal of Pharmacy and Technology

JF - Research Journal of Pharmacy and Technology

SN - 0974-3618

IS - 9

ER -